SEC 13F Intelligence

Managers / Q3 2019 · view latest →

Crestline Management, L.P.

CIK 0001536054 · 201 MAIN STREET, SUITE 2100, FORT WORTH, TX, 76102 · 817.339.7483

Reported Value
$621M
Q3 2019
Positions
79
Filings on Record
31
2019–present window
Filed
Nov 13, 2019
original filing

Summary

Crestline Management, L.P. reported $621M in U.S.-listed holdings across 79 positions for Q3 2019.

The portfolio is heavily concentrated: DNLI alone accounts for 48.0% of reported value.

Compared with Q2 2019, the fund opened 44 new positions and exited 47.

Portfolio Metrics

Turnover
+25.6%
vs prior filed quarter
Top-10 Concentration
+67.6%
share of reported value
Largest Position
+48.0%
Denali Therapeutics
New / Exited
44 / 47
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $461MQ1 ’19Q2 ’19: $743MQ3 ’19: $621MQ4 ’19: $772MQ1 ’20: $347MQ1 ’20Q2 ’20: $546MQ3 ’20: $678MQ4 ’20: $943MQ1 ’21: $788MQ1 ’21Q2 ’21: $1.2BQ3 ’21: $1.1BQ4 ’21: $1.3BQ1 ’22: $834MQ1 ’22Q2 ’22: $766MQ3 ’22: $740MQ4 ’22: $682MQ1 ’23: $842MQ1 ’23Q2 ’23: $958MQ3 ’23: $858MQ4 ’23: $1.2BQ1 ’24: $1.1BQ1 ’24Q2 ’24: $1.3BQ3 ’24: $1.9BQ4 ’24: $3.0BQ1 ’25: $63MQ1 ’25Q2 ’25: $63MQ3 ’25: $58MQ4 ’25: $53MQ1 ’26: $46MQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 72.1%REIT: 21.3%Other: 3.9%ETP: 2.5%ADR: 0.2%
  • Common Stock · 72.1% · $448M
  • REIT · 21.3% · $132M
  • Other · 3.9% · $24M
  • ETP · 2.5% · $16M
  • ADR · 0.2% · $1M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
FEDERAL REALTY INVT TRNEW+98.3K98.3K+$13M$13M
SPYSPDR S&P 500 ETF TRNEW+38.7K38.7K+$11M$11M
NNNNATIONAL RETAIL PPTYS INCNEW+192.6K192.6K+$11M$11M
HIWHIGHWOODS PPTYS INCNEW+179.8K179.8K+$8M$8M
REGNREGENERON PHARMACEUTICALSNEW+28.5K28.5K+$8M$8M
BLACKROCK INCNEW+13.4K13.4K+$6M$6M
PYPLPAYPAL HLDGS INCNEW+55.3K55.3K+$6M$6M
PREMIER INCNEW+180.0K180.0K+$5M$5M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2019

79 positions
#IssuerClass% PortfolioValueShares
1DNLIDENALI THERAPEUTICS INChistory →COM48.02%$298M19.46M
2AREALEXANDRIA REAL ESTATE EQ INhistory →COM2.72%$17M109.6K
3AMHAMERICAN HOMES 4 RENThistory →CL A2.50%$16M600.7K
4AATAMERICAN ASSETS TR INChistory →COM2.47%$15M328.3K
5HUDSON PAC PPTYS INCCOM2.35%$15M435.9K
6PARAMOUNT GROUP INCCOM2.17%$13M1.01M
7FEDERAL REALTY INVT TRSH BEN INT NEW2.16%$13M98.3K
8SPYSPDR S&P 500 ETF TRhistory →TR UNIT1.85%$11M38.7K
9NNNNATIONAL RETAIL PPTYS INChistory →COM1.75%$11M192.6K
10CICIGNA CORP NEWhistory →COM1.65%$10M67.5K
11SHOSUNSTONE HOTEL INVS INC NEWhistory →COM1.39%$9M629.7K
12HIWHIGHWOODS PPTYS INChistory →COM1.30%$8M179.8K
13REGNREGENERON PHARMACEUTICALShistory →COM1.27%$8M28.5K
14SPIRIT RLTY CAP INC NEWCOM NEW1.20%$7M156.0K
15TRTXTPG RE FIN TR INChistory →COM1.20%$7M374.3K
16SYFSYNCHRONY FINLhistory →COM1.09%$7M198.2K
17BLACKROCK INCCOM0.96%$6M13.4K
18MYLAN N VSHS EURO0.96%$6M300.0K
19PYPLPAYPAL HLDGS INCCOM0.92%$6M55.3K
20LPLALPL FINL HLDGS INCCOM0.91%$6M68.8K
21PREMIER INCCL A0.84%$5M180.0K
22EVREVERCORE INCCLASS A0.82%$5M63.9K
23UNHUNITEDHEALTH GROUP INCCOM0.79%$5M22.5K
24FCPTFOUR CORNERS PPTY TR INCCOM0.76%$5M167.9K
25CNCCENTENE CORP DELCOM0.71%$4M102.5K
26ALLALLSTATE CORPCOM0.70%$4M40.2K
27ACGLARCH CAP GROUP LTDORD0.70%$4M103.4K
28FXEINVESCO CURRENCYSHARES EUROEURO SHS0.68%$4M40.8K
29HSTHOST HOTELS & RESORTS INCCOM0.64%$4M229.5K
30GTSTRIPLE-S MGMT CORPCL B0.63%$4M290.0K
31INVHINVITATION HOMES INCCOM0.61%$4M128.8K
32PRUPRUDENTIAL FINL INCCOM0.60%$4M41.5K
33LNCLINCOLN NATL CORP INDCOM0.57%$4M58.8K
34CXWCORECIVIC INCCOM0.53%$3M190.0K
35GILDGILEAD SCIENCES INCCOM0.51%$3M50.0K
36NFLXNETFLIX INCCOM0.49%$3M11.3K
37UTHRUNITED THERAPEUTICS CORP DELCOM0.48%$3M37.5K
38ALLYALLY FINL INCCOM0.46%$3M86.7K
39TARO PHARMACEUTICAL INDS LTDSHS0.45%$3M37.0K
40RFREGIONS FINL CORP NEWCOM0.44%$3M171.1K
41METAFACEBOOK INCCL A0.42%$3M14.8K
42AXSAXIS CAPITAL HOLDINGS LTDSHS0.42%$3M39.4K
43CAHCARDINAL HEALTH INCCOM0.42%$3M55.0K
44PLYMPLYMOUTH INDL REIT INCCOM0.41%$3M138.9K
45TIVITY HEALTH INCCOM0.40%$2M150.0K
46EVHEVOLENT HEALTH INCCL A0.39%$2M335.0K
47RJFRAYMOND JAMES FINANCIAL INCCOM0.34%$2M25.5K
48AXPAMERICAN EXPRESS COCOM0.33%$2M17.1K
49ALKSALKERMES PLCSHS0.32%$2M102.5K
50CFGCITIZENS FINL GROUP INCCOM0.31%$2M55.0K
51PDL BIOPHARMA INCCOM0.30%$2M875.0K
52KMPRKEMPER CORP DELCOM0.30%$2M24.1K
53PATTERSON COMPANIES INCCOM0.30%$2M105.0K
54CMACOMERICA INCCOM0.28%$2M26.6K
55FITBFIFTH THIRD BANCORPCOM0.28%$2M63.6K
56CBCHUBB LIMITEDCOM0.28%$2M10.6K
57ARAYACCURAY INCCOM0.27%$2M600.0K
58RGAREINSURANCE GRP OF AMERICA ICOM NEW0.26%$2M10.2K
59ETRAE TRADE FINANCIAL CORPCOM NEW0.26%$2M37.0K
60FAFFIRST AMERN FINL CORPCOM0.24%$1M25.3K
61CORAMERISOURCEBERGEN CORPCOM0.23%$1M17.5K
62IRWDIRONWOOD PHARMACEUTICALS INCCOM CL A0.19%$1M140.0K
63HIGHARTFORD FINL SVCS GROUP INCCOM0.19%$1M19.6K
64HCMHUTCHISON CHINA MEDITECH LTDSPONSORED ADR0.18%$1M63.4K
65CSCOCISCO SYS INCCOM0.17%$1M20.8K
66JANUS HENDERSON GROUP PLCORD SHS0.15%$903,00040.2K
67APOLLO GLOBAL MGMT INCCOM CL A0.13%$837,00022.1K
68INTRICON CORPCOM0.13%$816,00042.0K
69LMEURLEGG MASON INCCOM0.12%$765,00020.0K
70HMNHORACE MANN EDUCATORS CORP NCOM0.12%$747,00016.1K
71MDMEDNAX INCCOM0.12%$724,00032.0K
72EHCENCOMPASS HEALTH CORPCOM0.10%$633,00010.0K
73NUVECTRA CORPCOM0.09%$544,000400.0K
74NVSTENVISTA HLDGS CORPCOM0.05%$318,00011.4K
75SONOSONOS INCCOM0.05%$303,00022.6K
76MMACYS INCCOM0.05%$292,00018.8K
77SDCCQSMILEDIRECTCLUB INCCL A COM0.04%$278,00020.0K
78AXGNAXOGEN INCCOM0.04%$250,00020.0K
79WRIGHT MED GROUP N VORD SHS0.03%$206,00010.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$46M3May 15, 2026RESTATEMENTchanges · EDGAR ↗
Q4 2025$53M3Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$58M3Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$63M3Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$63M3May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$3.0B705Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$1.9B514Nov 13, 202413F-HRchanges · EDGAR ↗
Q2 2024$1.3B159Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$1.1B157May 14, 202413F-HRchanges · EDGAR ↗
Q4 2023$1.2B157Feb 12, 202413F-HRchanges · EDGAR ↗
Q3 2023$858M143Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$958M148Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$842M157May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$682M165Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022$740M201Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$766M221Aug 12, 202213F-HRchanges · EDGAR ↗
Q1 2022$834M256May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.3B227Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.1B236Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.2B177Aug 13, 202113F-HRchanges · EDGAR ↗
Q1 2021$788M98May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$943M141Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$678M91Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$546M160Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$347M32May 13, 2020RESTATEMENTchanges · EDGAR ↗
Q4 2019$772M41Feb 12, 202013F-HRchanges · EDGAR ↗
Q3 2019$621M79Nov 13, 201913F-HRchanges · EDGAR ↗
Q2 2019$743M82Aug 13, 201913F-HRchanges · EDGAR ↗
Q1 2019$461M3May 15, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • Oribel Capital Management, LP028-17769

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.